Shenzhen Weiguang Biological Products Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 411.43 million compared to CNY 616.76 million a year ago. Revenue was CNY 411.43 million compared to CNY 616.76 million a year ago.

Net income was CNY 72.77 million compared to CNY 137.67 million a year ago. Basic earnings per share from continuing operations was CNY 0.3209 compared to CNY 0.607 a year ago. Diluted earnings per share from continuing operations was CNY 0.3209 compared to CNY 0.607 a year ago.